Immortal Time and Selection Biases in Study of Direct-Acting Antiviral Treatment and Hepatitis C Outcomes
- PMID: 37067790
- DOI: 10.1001/jamainternmed.2023.0554
Immortal Time and Selection Biases in Study of Direct-Acting Antiviral Treatment and Hepatitis C Outcomes
Comment in
-
Immortal Time and Selection Biases in Study of Direct-Acting Antiviral Treatment and Hepatitis C Outcomes-Reply.JAMA Intern Med. 2023 Jun 1;183(6):625. doi: 10.1001/jamainternmed.2023.0557. JAMA Intern Med. 2023. PMID: 37067818 No abstract available.
Comment on
-
Association of Direct-Acting Antiviral Therapy With Liver and Nonliver Complications and Long-term Mortality in Patients With Chronic Hepatitis C.JAMA Intern Med. 2023 Feb 1;183(2):97-105. doi: 10.1001/jamainternmed.2022.5699. JAMA Intern Med. 2023. PMID: 36508196 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
